Developing a cross-industry digital compliance solution to revolutionise, democratise and streamline corporate due diligence for businesses
Developing a cross-industry digital compliance solution to revolutionise, democratise and streamline corporate due diligence for businesses
批准号:
10008674
负责人:
金额:
$30.9万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Umazi is seeking to provide institutions with a cross-industry digital compliance solution that drastically reduces the complexity of compliance processes and improves efficiency by automating repeatable steps; using blockchain technology.Businesses that transact with each other often conduct due diligence on each other. This due diligence requires the verification of identity and credentials, making sure the organisation is legitimate and low-risk. Traditional due diligence processes are a cumbersome, manual, time-consuming exercise, and vary from organisation to organisation; making the process repetitive and costly.Umazi simplifies the due diligence process by leveraging distributed ledger technology to create a cryptographically secure corporate identity. The distributed ledger facilitates a secure and immutable way for the corporate to control and share their identity. The process becomes automated and streamlined. For financially regulated institutions this means better regulatory compliance, less regulatory, operational and reputational risk and improved KYC (corporate customers) and onboarding experience with customers. Alongside, significant back-office cost-savings.These benefits apply across all industries where it's important to verify the identity of your trading partner, such as large corporate partnerships and manufacturing outsource agreements; Umazi's solution is the same for all of them. The solution provides an exchange for a verified corporate identity, regardless of industry, country or language.Due diligence is a thorough appraisal of a business that a potential investor or buyer will undertake before engaging in a business deal. If you're the party doing the buying or investing, your lawyer will review the target company's assets & liabilities, structure, operations and business relationships.Financially regulated institutions (e.g. banks, insurers, law firms, real-estate, etc.) are required by law to conduct due diligence and risk assessments on clients. Tier-1 banks spend 15% of their costs/year on compliance. These institutions lose ~10% of customers due to onboarding friction. In 2012, the US Treasury's Financial Crimes Enforcement Network announced work on a new due diligence rule that would compel collection of ultimate beneficial ownership information. The publication of the Panama Papers in April 2016 accelerated the process, when the millions of leaked documents included in this trove detailed how offshore shell corporations have been used for money laundering, tax evasion and other illegal purposes. One month after they were released to the public, the US Treasury issued its Customer Due Diligence Rule. These events have spurred a global race for enhanced corporate due diligence that is sector-agnostic, cross-jurisdictional and independent of language.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
胰岛素样生长信号介导的肺巨噬细胞和上皮细胞cross-tolk通过核自噬参与慢性气道炎症形成的机制研究
-
批准号:JCZRYB202500229
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
-
批准号:2025JJ80174
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹菊英
-
依托单位:
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
-
批准号:JCZRYB202500379
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于破骨-成骨细胞Cross-Talk探讨内固定物存留对关节软骨退变的影响及补肾强骨治法的科学内涵
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
三痹汤激活线粒体自噬影响免疫细胞Cross talk延缓椎间盘退变的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王楠
-
依托单位:
多环芳烃(PAHs )介导的癌细胞和Th17细胞“cross-talk”所
致免疫抑制反应在胶质瘤增殖侵袭中的作用及毒理学机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
PGK1乙酰化修饰介导癌细胞与TAMs间Cross-talk调控胆囊癌EMT的研究
-
批准号:82373032
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王剑明
-
依托单位:
生长激素受体通过脂肪酸介导的肝脏-脂肪Cross-talk影响脂质内稳态的研究
-
批准号:82370866
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴英杰
-
依托单位:
线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
-
批准号:82370171
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴俣
-
依托单位:
基于“cross-β折叠”结构形成理论解析面筋蛋白淀粉样纤维的形成机制
-
批准号:32372365
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:张慧娟
-
依托单位: